Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 20 items.
A new presentation of SPIKEVAX (elasomeran) with a concentration of 0.10 mg/mL in a 2.5 mL multidose vial was authorized on June 01, 2022. In order to provide rapid access to the new presentation of SPIKEVAX (0.10 mg/mL, 2.5 mL multidose vial), Moderna…
AlertHealth professional risk communication | 2022-06-06
Label does not meet Health Canada requirements
RecallHealth product recall | 2022-05-27
EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…
AlertHealth professional risk communication | 2022-04-14
The lot number and/or expiration date may not appear on the affected lot label.
RecallHealth product recall | 2022-04-06
NUVAXOVID was authorized by Health Canada on February 17, 2022. In order to provide earlier access to NUVAXOVID in the context of the global pandemic, Novavax, Inc. will distribute product vials, cartons and package inserts that are in English only for a…
AlertHealth professional risk communication | 2022-02-23
Affected lot(s) may be missing risk statements and the non medicinal ingredient carbomer on the outer label.
RecallHealth product recall | 2022-02-23
UPDATED INFORMATION - July 6, 2022
A new PAXLOVID dose pack for use in patients with moderate renal impairment (eGFR ≥30 to <60 mL/min) is now available with a distinct DIN: 02527804. Pfizer has introduced this new packaging configuration to…
AlertHealth professional risk communication | 2022-01-17
On December 23, 2021, Health Canada authorized a shelf-life extension, from 7 months to 9 months, for SPIKEVAX / COVID-19 Vaccine Moderna 5 mL vials. This 2-month extension may be retroactively applied to vials that are currently on the market with…
AlertHealth professional risk communication | 2022-01-11
Affected lot is labelled with unauthorized claims and ingredients including cetylpyridinium chloride. The product lablel is missing risk statements, the NPN and is incorrectly labelled for use in children.
RecallHealth product recall | 2021-12-24
Affected lot(s) is/are labelled with incorrect expiry date and storage conditions found on the bottle.
RecallHealth product recall | 2021-12-01
UPDATED INFORMATION – October 29, 2021
Further to the Health Canada communications below issued on June 14, 2021 (and updated on June 24, 2021, and August 3, 2021), Health Canada has authorized a 2-month shelf life extension (from 7 months to 9 months…
AlertHealth professional risk communication | 2021-06-14
One lot of Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream recalled because of a labelling error regarding use in children under two years of age
Starting date:…
AlertPublic advisory | 2019-12-23
Duchesnay Inc. recalls certain lots of PregVit and PregVit folic 5 prenatal and postpartum vitamin-mineral supplements because of a packaging error
Starting date:
November 15…
AlertPublic advisory | 2019-11-15
Labelling error may lead to patients receiving Linessa 28 birth control pills instead of Linessa 21
Starting date:
June 12, 2019
Type of communication:
Advisory
Subcategory:…
AlertPublic advisory | 2019-06-12
Recall of Cannabis for Medical Purposes - CannTrust Inc.
Starting date:
January 4, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III…
RecallHealth product recall | 2019-01-04